Stop TB Partnership

Global Fund Board issues major announcements

15 November 2012 - Geneva - The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria took four major decisions today of great importance for the TB community and TB-affected communities.

  1. Ambassador Mark R Dybul, a former United States Global AIDS Coordinator, was appointed as the Global Fund's new Executive Director. Dr Dybul helped create and then lead the President's Emergency Program for AIDS Relief, known as PEPFAR. Trained as a medical doctor with a specialty in immunology, he became an expert on AIDS as a clinician, scientist and administrator. "We welcome the appointment of Dr Dybul as Executive Director of the Global Fund, and we hope that he will bring a new spirit of commitment to addressing TB and seek funding equity for AIDS, TB and malaria," said Dr Lucica Ditiu, Executive Secretary of the Stop TB Partnership.
  2. The Board voted in an immediate transition to a new funding model that was adopted in September (see Special consideration will be given to countries applying with programs that are, among other things, underfunded over the 2013-2014 period or at risk of service interruptions or judged to be in a position to achieve rapid impact . Under the new approach, countries will be grouped in bands, which the Global Fund says will enable the Board to ensure focus is placed on countries with the highest disease burden and the least ability to pay, among other factors. The new funding model will replace the rounds-based system.
  3. The Board terminated the employment of its Inspector General, John Parsons. The Board decision came after a careful review of his performance, which was found to be unsatisfactory. Mr Parsons was responsible for overseeing audits and investigations by the Office of the Inspector General, whose mission is to provide the Global Fund with independent and objective assurance over the design and effectiveness of controls in place to manage risks affecting programs supported by the Global Fund. The Board expects the search for a new Inspector General to take about six months. An interim Inspector General will be appointed shortly.
  4. The Board decided to integrate the Affordable Medicines Facility - malaria (AMFm) into core Global Fund grant management. The AMFm was created to improve access to artemisinin-based combination therapies (ACTs), the most effective anti-malaria treatment.